SCHEMBL26906352

SCHEMBL26906352

CC1(C)OB(c2ccn3nc(NC(=O)O)cc3c2)OC1(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.41
ABL1 P00519 1/20 0.41
MAPK8 P45983 1/20 0.41
CSNK1A1 P48729 1/20 0.41
CDK7 P50613 1/20 0.41
TYRO3 Q06418 1/20 0.41
LRRK2 Q5S007 1/20 0.41
AURKB Q96GD4 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
HIF1A Q16665 3/20 0.36
PDGFRB P09619 2/20 0.35
KDR P35968 2/20 0.35
CA1 P00915 4/20 0.35
CA2 P00918 4/20 0.35
CA9 Q16790 4/20 0.35
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34
GSK3A P49840 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26906310 0.86 SIK1 (0.41) MAP4K4ABL1MAPK8CSNK1A1CDK7
SCHEMBL24305581 0.86 MAP4K4 (0.38) MAP4K4ABL1MAPK8CSNK1A1CDK7
SCHEMBL26906155 0.84 PRMT5 (0.43) MAP4K4ABL1MAPK8CSNK1A1CDK7
SCHEMBL24284598 0.82 MAP4K1 (0.48) MAP4K4ABL1MAPK8CSNK1A1CDK7
SCHEMBL25200891 0.82 IRAK4 (0.39) HIF1ACA1CA2CA9IDO1
SCHEMBL27228985 0.81 DEGS1 (0.44) MAP4K4ABL1MAPK8CSNK1A1CDK7
SCHEMBL25440296 0.77 TDP2 (0.38) HIF1APDGFRBKDRCA1CA2
SCHEMBL29770683 0.77 POLB (0.34) IDO1TDO2IRAK4
SCHEMBL26905997 0.77 POLB (0.34) IDO1TDO2IRAK4
SCHEMBL26906261 0.75 LPL (0.35) PDGFRBKDRCA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174662-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES CILAG AG (CH) 2024-05-30 US disclosed
US-20240158392-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES JANSSEN RESEARCH & DEVELOPMENT, LLC 2024-05-16 US disclosed
EP-4284801-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES Janssen Biotech, Inc. (US) 2023-12-06 EP disclosed
EP-4284802-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES Janssen Biotech, Inc. (US) 2023-12-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240158392-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES SIK2, SIK1, SGK2 MAP4K4 74/4885ABL1 555/4885MAPK8 239/4885
US-20240174662-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES SIK2, SIK1, SGK2 MAP4K4 69/4885ABL1 562/4885MAPK8 230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.